A Prospective Multicenter Study on Patients'Satisfaction With Angeliq® Micro in Real Clinical Practice Conducted in Russia
NCT03126773 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1570
Last updated 2021-06-18
Summary
To evaluate the patients' satisfaction with Angeliq Micro in real clinical practice after 13 cycles of treatment.
Conditions
Interventions
- DRUG
-
BAY86-4891
Drospirenone 0.25 mg + estradiol hemihydrate 0.5 mg (Angeliq Micro, G03FA17).Dosage form is one tablet a day.
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 50 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-02
- Primary Completion
- 2019-11-30
- Completion
- 2020-06-18
Countries
- Russia
More Related Trials
-
Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B in Perimenopausal Women.
NCT03897738 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome
NCT03118908 ·Status: COMPLETED ·Phase: NA
-
Vaginal and Urinary Microbiome Trial
NCT02869165 ·Status: COMPLETED ·Phase: PHASE4
-
Changes in Neighbouring Microbiota in Genitourinary Syndrome
NCT06633705 ·Status: COMPLETED ·Phase: PHASE4
-
Menopausal Symptoms Probiotic Study
NCT06446869 ·Status: RECRUITING ·Phase: NA
-
Sustainability of Vaginal Estrogen Therapy in Postmenopausal Women
NCT02887885 ·Status: COMPLETED
-
Effect of Menopausal Hormone Therapy on Immune System Parameters
NCT05678192 ·Status: COMPLETED ·Phase: PHASE1
-
Diet, Cardiometabolic Risk (CM) and Menopause Symptoms
NCT05764473 ·Status: COMPLETED ·Phase: NA
-
Use of Fractional CO2 Laser Versus Erbium:YAG Laser for the Treatment of GSM in Patients Using Aromatase Inhibitors
NCT05713435 ·Status: RECRUITING ·Phase: NA
-
One Week Clinical Study in Subjects With Menopausal Symptoms
NCT06794021 ·Status: COMPLETED ·Phase: NA
-
The Benefits and Risks of Different Menopausal Hormone Replacement Therapy Regimes in the Treatment of Menopause Syndrome
NCT03436303 ·Status: UNKNOWN ·Phase: PHASE4
-
ZK283197 for Treatment of Vasomotor Symptoms
NCT00537836 ·Status: COMPLETED ·Phase: PHASE2
-
Estrogen Hormone Products
NCT05645406 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Clinical Efficacy of Hormone Replacement Therapy in Treating Perimenopausal Women With MGD
NCT04962386 ·Status: UNKNOWN
-
Pilot Study to Investigate the Impact of an App on the Quality of Life and Symptoms of Individuals Affected by Menopause
NCT06987617 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo
NCT01779947 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (RF-SGM)
NCT07034976 ·Status: RECRUITING ·Phase: NA
-
Assessing the Synergistic Effects of Black Cohosh, Soy Isoflavones, and SDG Lignans (Soloways TM) on Menopausal Symptoms
NCT06328348 ·Status: COMPLETED ·Phase: NA
-
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.
NCT06962345 ·Status: RECRUITING ·Phase: NA
-
A Randomized Controlled Trial of Menopausal Tool/App for Women
NCT06919887 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause
NCT05672901 ·Status: RECRUITING ·Phase: NA
-
Oral Contraceptive During Menopausal Transition
NCT01414530 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Estradiol and Progesterone Microspheres for the Treatment of Climacteric Symptoms.
NCT00775242 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phytoserms for Menopause Symptoms and Age-Associated Memory Decline
NCT01723917 ·Status: COMPLETED ·Phase: NA
-
A Pooled Analysis of the Data From Two Studies of Ammonium Succinate for Menopausal Symptoms
NCT03043690 ·Status: COMPLETED